A Study to Establish an Eclipse Continence System Registry

Overview

About this study

The purpose of this study is to to evaluate the safety and effectiveness of the Eclipse System for the treatment of Fecal Incontinence (FI) in adult women.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Adult female, age 18 years or older.
  • Diagnosis of Fecal Incontinence.
  • Clinician recommendation of the Eclipse System.
  • Subject provides informed consent and HIPAA authorization.

Exclusion Criteria:

  • Females under 18 years of age.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

Paul Pettit, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available
.
CLS-20467363

Mayo Clinic Footer